Pedro Rafael Dimbu, Sarah Labuda, Carolina Miguel Ferreira, Felismina Caquece, Kialanda André, Garcia Pembele, Dilunvuidi Pode, Maria Florinda João, Venceslau Mambi Pelenda, Benjamin Nieto Andrade, Breanna Horton, Culzean Kennedy, Samaly S Svigel, Zhiyong Zhou, Joana F M Morais, Joana do Rosário, Filomeno Fortes, José Franco Martins, Mateusz M Plucinski
Monitoring antimalarial efficacy is important to detect the emergence of parasite drug resistance. Angola conducts in vivo therapeutic efficacy studies (TESs) every 2 years in its fixed sentinel sites in Benguela, Lunda Sul, and Zaire provinces. Children with uncomplicated Plasmodium falciparum malaria were treated with artemether-lumefantrine (AL), artesunate-amodiaquine (ASAQ), dihydroartemisinin-piperaquine (DP), or artesunate-pyronaridine (ASPY) and followed for 28 (AL and ASAQ) or 42 days (DP and ASPY) to assess clinical and parasitological response to treatment...
February 29, 2024: Antimicrobial Agents and Chemotherapy